MYSM1 co-activates ERα action via histone and non-histone deubiquitination to confer antiestrogen resistance in breast cancer
Y. Zhao, R. Luan, G. Sun, B. Zhou, M. Wang, Y. Bai, C. Wang, S. Wang, K. Zeng, J. Feng, M. He, L. Lin, Y. Wei, Q. Zhang
This study identifies MYSM1 as an ER co-activator that promotes antiestrogen resistance in breast cancer through histone and non-histone deubiquitination.
bioRxiv · Dec 23, 2022 · PreprintCell Biology